Roato Ilaria, Chinigò Giorgia, Genova Tullio, Munaron Luca, Mussano Federico
Department of Surgical Sciences, CIR-Dental School, University of Torino, 10126 Torino, Italy.
Department of Life Sciences and Systems Biology, University of Torino, 10123 Torino, Italy.
Biomedicines. 2021 Aug 25;9(9):1085. doi: 10.3390/biomedicines9091085.
The use of mesenchymal stem cells (MSCs) for regenerative purposes has become common in a large variety of diseases. In the dental and maxillofacial field, there are emerging clinical needs that could benefit from MSC-based therapeutic approaches. Even though MSCs can be isolated from different tissues, such as bone marrow, adipose tissue, etc., and are known for their multilineage differentiation, their different anatomical origin can affect the capability to differentiate into a specific tissue. For instance, MSCs isolated from the oral cavity might be more effective than adipose-derived stem cells (ASCs) for the treatment of dental defects. Indeed, in the oral cavity, there are different sources of MSCs that have been individually proposed as promising candidates for tissue engineering protocols. The therapeutic strategy based on MSCs can be direct, by using cells as components of the tissue to be regenerated, or indirect, aimed at delivering local growth factors, cytokines, and chemokines produced by the MSCs. Here, the authors outline the major sources of mesenchymal stem cells attainable from the oral cavity and discuss their possible usage in some of the most compelling therapeutic frontiers, such as periodontal disease and dental pulp regeneration.
间充质干细胞(MSCs)用于再生目的在多种疾病中已变得很常见。在口腔颌面领域,存在一些新出现的临床需求,可能会从基于MSCs的治疗方法中受益。尽管MSCs可以从不同组织中分离出来,如骨髓、脂肪组织等,并且以其多向分化能力而闻名,但其不同的解剖学来源会影响其分化为特定组织的能力。例如,从口腔分离的MSCs在治疗牙齿缺损方面可能比脂肪来源干细胞(ASCs)更有效。事实上,在口腔中,有不同来源的MSCs,它们已被分别提议作为组织工程方案中有前景的候选者。基于MSCs的治疗策略可以是直接的,即将细胞用作待再生组织的组成部分,也可以是间接的,旨在递送由MSCs产生的局部生长因子、细胞因子和趋化因子。在此,作者概述了可从口腔获得的间充质干细胞的主要来源,并讨论了它们在一些最引人注目的治疗前沿领域,如牙周病和牙髓再生中的可能用途。